464 related articles for article (PubMed ID: 17576400)
21. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy.
Cumming DC
Arch Intern Med; 1996 Oct; 156(19):2193-5. PubMed ID: 8885817
[TBL] [Abstract][Full Text] [Related]
22. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
23. Dry eye in post-menopausal women using hormone replacement therapy.
Erdem U; Ozdegirmenci O; Sobaci E; Sobaci G; Göktolga U; Dagli S
Maturitas; 2007 Mar; 56(3):257-62. PubMed ID: 17030104
[TBL] [Abstract][Full Text] [Related]
24. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
Guinot C; Malvy D; Ambroisine L; Latreille J; Mauger E; Guéhenneux S; Morizot F; Tschachler E
Skin Res Technol; 2005 Aug; 11(3):201-4. PubMed ID: 15998332
[TBL] [Abstract][Full Text] [Related]
25. A 10-year follow-up of the effect of continuous-combined hormone replacement therapy and its discontinuation on bone in postmenopausal women.
Heikkinen J; Vaheri R; Haapalahti J; Timonen U
Menopause Int; 2008 Jun; 14(2):70-7. PubMed ID: 18519268
[TBL] [Abstract][Full Text] [Related]
26. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
[TBL] [Abstract][Full Text] [Related]
27. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
Prázný M; Fait T; Vrablik M
Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
[TBL] [Abstract][Full Text] [Related]
28. [What's new in hormone replacement therapy for postmenopausal women? I. Advantages of hormone replacement therapy (HRT)].
Martin-Du Pan RC; Luzuy F
Rev Med Suisse Romande; 2000 Jun; 120(6):515-21. PubMed ID: 11014096
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of efficacy of estrogen and phytotherapy in oral cavity alterations of women in menopause.
Giuca MR; Carli E; Pasini M; Bonfigli D; Cappè MR
Minerva Ginecol; 2009 Feb; 61(1):13-22. PubMed ID: 19204657
[TBL] [Abstract][Full Text] [Related]
30. [The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression].
Yazici K; Pata O; Yazici A; Aktaş A; Tot S; Kanik A
Turk Psikiyatri Derg; 2003; 14(2):101-5. PubMed ID: 12844276
[TBL] [Abstract][Full Text] [Related]
31. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
Johansen OE; Qvigstad E
Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
[TBL] [Abstract][Full Text] [Related]
32. [Assessment of the association of Kava-Kava extract and hormone replacement therapy in the treatment of postmenopause anxiety].
De Leo V; La Marca A; Lanzetta D; Palazzi S; Torricelli M; Facchini C; Morgante G
Minerva Ginecol; 2000 Jun; 52(6):263-7. PubMed ID: 11085051
[TBL] [Abstract][Full Text] [Related]
33. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Pullerits R; d'Elia HF; Tarkowski A; Carlsten H
Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946
[TBL] [Abstract][Full Text] [Related]
34. The role of hormone replacement therapy in endometrial polyp formation.
Oguz S; Sargin A; Kelekci S; Aytan H; Tapisiz OL; Mollamahmutoglu L
Maturitas; 2005 Mar; 50(3):231-6. PubMed ID: 15734604
[TBL] [Abstract][Full Text] [Related]
35. Hormonal replacement therapy in surgical menopause with underlying endometriosis.
Rattanachaiyanont M; Tanmahasamut P; Angsuwatthana S; Techatraisak K; Inthawiwat S; Leerasiri P
J Med Assoc Thai; 2003 Aug; 86(8):702-7. PubMed ID: 12948267
[TBL] [Abstract][Full Text] [Related]
36. Hormonal replacement therapy after stem cell transplantation.
Piccioni P; Scirpa P; D'Emilio I; Sora F; Scarciglia M; Laurenti L; De Matteis S; Sica S; Leone G; Chiusolo P
Maturitas; 2004 Dec; 49(4):327-33. PubMed ID: 15531129
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate].
Collette J; Viethel P; Dethor M; Chevallier T; Micheletti MC; Foidart JM; Reginster JY
Gynecol Obstet Fertil; 2003 May; 31(5):434-41. PubMed ID: 14567121
[TBL] [Abstract][Full Text] [Related]
38. Effects of estrogen/androgen therapy on bone mineral density parameters.
Notelovitz M
J Reprod Med; 2001 Mar; 46(3 Suppl):325-31. PubMed ID: 11304880
[TBL] [Abstract][Full Text] [Related]
39. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
[TBL] [Abstract][Full Text] [Related]
40. [Hormone replacement therapy (HRT). The effects at 12 months on the risk factors for menopausal osteoporosis].
Camilli A; Di Benedetto L; Camilli FM; Ermini M
Minerva Ginecol; 1997 May; 49(5):193-8. PubMed ID: 9304078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
